Welcome to our dedicated page for Micromen Tech news (Ticker: MMTIF), a resource for investors and traders seeking the latest updates and insights on Micromen Tech stock.
Micromem Technologies Inc. reports developments in proprietary nanotechnology and advanced sensor platforms for real-time detection applications. Company updates focus on gas-phase and liquid-phase sensing work, including nanowire field-effect transistor biochemical sensors, wearable and portable detection systems, and applications in defense, environmental monitoring, industrial safety, oil and gas, healthcare, and other industrial markets.
Recurring news also covers Micromem's collaboration with the Department of National Defence, Defence Research and Development Canada, and the University of Toronto, along with progress in biomarker detection, chemical-agent sensing, platform miniaturization, commercialization planning, capital-structure matters, and shareholder-related disclosures.
Micromem Technologies (OTCQB: MMTIF) received Department of National Defence approval for go-forward plans on the next phase of its wearable gas sensing project under an existing collaboration with the University of Toronto.
This phase adds two researchers, targets functional wearable prototypes, and advances proprietary nanowire gas-sensing technology toward dual-use defense and commercial applications.
Micromem Technologies (OTCQB: MMTIF) engaged two University of Toronto engineering students to advance its wearable gas sensing project under a collaborative research agreement with Canada’s Department of National Defence and the University.
The students will support software and hardware for low-power wearable architectures that adapt Micromem’s nanowire gas-sensing technology to real-world defense and industrial applications, with the goal of functional wearable prototypes, followed by validation testing with defense stakeholders and potential commercial partners.
Micromem Technologies (OTCQB: MMTIF) provided an update on its gas-phase sensor development under a collaborative agreement with the Department of National Defence and the University of Toronto on April 6, 2026.
The company reports progress toward a wearable, low-power gas sensor platform targeting zeptofarad-level sensitivity for real-time detection across environmental monitoring, industrial safety, healthcare diagnostics, energy infrastructure, and defense applications. Micromem says it is refining sensor architecture, signal processing, and system integration to support compact, field-deployable designs and will evaluate strategic partnerships for military and commercial deployment.
Micromem Technologies (OTCQB: MMTIF) reported technical progress on its liquid-phase NWFET (Nanowire Field‑Effect Transistor) sensor under a Research Collaboration Agreement with the University of Toronto and Defence Research and Development Canada.
Highlights: successful detection of clinically relevant biomarkers including TREM-1 at low concentrations, new on‑chip electrode mask designs, optimized photolithography, and work toward integrated portable microfluidic platforms. Near-term work includes further biomarker validation and completion of microfluidic integration to advance toward defence and medical diagnostics applications.
Micromem Technologies (OTCQB: MMTIF) provided a corporate update outlining 2026 strategic priorities and technical progress. The company is advancing its AI-enhanced nanowire sensor platforms, expanding focus from oil & gas to defence and industrial systems, and pursuing commercialization and IP protection.
Key collaboration partners include Defence Research and Development Canada (DRDC) and the University of Toronto, with meetings the week of February 9 to discuss a wearable biochemical sensor. The roadmap emphasizes enhanced detection, a smaller lower-cost hardware footprint, dual-use applications, and customer-driven validation toward near-term field products.
Micromem Technologies (OTCQB: MMTIF) closed a non‑brokered private placement on January 27, 2026, raising approximately C$327,778. The company issued 6,555,555 units at C$0.05 per unit, each unit consisting of one common share and one warrant exercisable at C$0.06 for one year.
All 6,555,555 common shares and 6,555,555 warrants were issued and are subject to a four‑month hold period. No insiders participated; subscribers are at arm's length. Micromem intends to use net proceeds for working capital. Closing remains subject to CSE post‑closing compliance. The securities are not registered under the U.S. Securities Act and have resale restrictions in the U.S.
Micromem (OTCQB: MMTIF) closed a tranche of a non-brokered private placement on January 14, 2026, raising gross proceeds of approximately C$327,778. The company issued 6,555,555 units at C$0.05 per unit, each unit comprising one common share and one warrant exercisable at C$0.06 for one year.
All securities are subject to a four-month hold period. No insiders participated and all subscribers were arm's length. The company may, at its discretion, close an additional tranche of up to C$167,000. Net proceeds are intended for working capital, and closing remains subject to customary post-closing CSE requirements.
Micromem Technologies (OTCQB: MMTIF) provided an operational update on October 27, 2025. Micromem met with University of Toronto on October 16, 2025 under the Collaboration Agreement executed February 25, 2025 with the Department of National Defence to advance gas and liquid sensing technologies.
The company reports the project is progressing well and remains on schedule. A follow-up meeting with UofT, NSERC and DRDC is expected before the end of calendar year 2025 to review progress and set the plan for 2026. Micromem also submitted a proposal to NATO DIANA; the 2025 submission was not advanced but Micromem intends to submit a revised proposal in 2026. Separate commercial discussions with Chevron continue. Micromem said it will update shareholders as developments occur.
Micromem (OTCQB: MMTIF) closed a non-brokered private placement on October 10, 2025, raising gross proceeds of C$498,652.
The company issued 9,066,400 units at C$0.055 per unit; each unit includes one common share and one warrant exercisable at C$0.06 per share for one year. All securities are subject to a four-month hold period. No insiders participated and all subscribers are arm's length. Micromem said net proceeds will be used for working capital. Closing remains subject to certain conditions, including post-closing compliance with the Canadian Securities Exchange. Securities were not registered under the U.S. Securities Act and cannot be offered in the U.S. without registration or an exemption.
Micromem Technologies (OTCQB: MMTIF) has unveiled a groundbreaking liquid-phase nanowire bio-chemical sensor designed for ultra-sensitive disease biomarker detection. The sensor achieves 1 picomolar detection limits and 20mV/decade sensitivity, specifically targeting TREM-1, a crucial inflammatory marker.
The platform, developed from work for the Department of National Defence, utilizes standard photolithography for cost-effective manufacturing. Key features include pM-level detection, customizable biomarker targeting, real-time output, and integration capability with point-of-care devices. The technology addresses a projected $100 billion USD biomarker diagnostics market by 2030.